Engineering Cellular Degradation of Multilayered Capsules through Controlled Cross-Linking
Source abstract
Abstract
We report a versatile approach for controlling the intracellular degradation of polymer capsules by tailoring the degree of cross-linking in the capsules. Poly(2-diisopropylaminoethyl methacrylate) capsules were assembled by the layer-by-layer technique and covalently stabilized with a redox-responsive bisazide cross-linker using click chemistry. The degree of cross-linking, determined using radiation scintillation counting, was tuned from 65% to 98% by adjusting the amount of cross-linker used to stabilize the polymer films. Transmission electron microscopy and fluorescence microscopy studies showed that the pH responsiveness of the capsules was maintained, regardless of the degree of cross-linking. Atomic force microscopy measurements on planar surfaces revealed that increasing the degree of cross-linking decreased the film roughness (from 8.7 to 1.7 nm), hence forming smoother films; however the film thicknesses were not significantly altered. Cellular studies showed that the rate of intracellular degradation of the capsules could be controlled between 0 and 6 h by altering the degree of cross-linking in the polymer capsules. These studies also demonstrated that the cellular degradation of highly cross-linked capsules (>90%) was significantly retarded compared to degradation in simulated cellular conditions. This suggests that the naturally occurring cellular reducing environment is rapidly depleted, and there is a significant delay before the cells can replenish the reducing environment. The modular and versatile nature of this approach lends itself to application to a wide range of polymer carriers and thus offers significant potential for the design of polymer-based systems for drug and gene delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biomolecular Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia
References (39)
Show source-provided references
1. Duncan R. · Nat. Rev. Drug Discovery · 2003 · 2 · 34710.1038/nrd1088 ↗
2. Dobrovolskaia M. A. · Nat. Nanotechnol. · 2007 · 2 · 46910.1038/nnano.2007.223 ↗
3. LaVan D. A. · Nat. Rev. Drug Discovery · 2002 · 1 · 7710.1038/nrd707 ↗
4. Such G. K. · Chem. Soc. Rev. · 2011 · 40 · 1910.1039/C0CS00001A ↗
5. Johnston A. P. R. · Small · 2009 · 5 · 141810.1002/smll.200900075 ↗
6. Owens D. E. · Int. J. Pharm. · 2006 · 307 · 9310.1016/j.ijpharm.2005.10.010 ↗
7. Johnston A. P. R. · Angew. Chem., Int. Ed. · 2010 · 49 · 266410.1002/anie.200906840 ↗
8. De Geest B. G. · Chem. Soc. Rev. · 2006 · 36 · 63610.1039/B600460C ↗
9. Tong R. · MRS Bull. · 2009 · 34 · 42210.1557/mrs2009.118 ↗
10. Delcea M. · Adv. Drug Delivery Rev. · 2011 · 63 · 73010.1016/j.addr.2011.03.010 ↗
11. Nishiyama N. · Pharmacol. Ther. · 2006 · 112 · 63010.1016/j.pharmthera.2006.05.006 ↗
12. Kim K. T. · Nanoscale · 2010 · 2 · 84410.1039/b9nr00409b ↗
13. De Geest B. G. · Adv. Mater. · 2006 · 18 · 100510.1002/adma.200502128 ↗
14. De Koker S. · Angew. Chem., Int. Ed. · 2009 · 48 · 848510.1002/anie.200903769 ↗
15. Rivera-Gil P. · Nano Lett. · 2009 · 9 · 439810.1021/nl902697j ↗
16. Duan H. · Langmuir · 2005 · 21 · 1149510.1021/la051638x ↗
17. Zhao M. · Biomaterials · 2011 · 32 · 522310.1016/j.biomaterials.2011.03.060 ↗
18. Ma Y. · Nat. Mater. · 2006 · 5 · 72410.1038/nmat1716 ↗
19. Leung M. K. M. · Small · 2011 · 7 · 107510.1002/smll.201002258 ↗
20. Kinnane C. R. · Biomacromolecules · 2009 · 10 · 283910.1021/bm900673m ↗
21. Ochs C. J. · ACS Nano · 2010 · 4 · 165310.1021/nn9014278 ↗
22. Such G. K. · Nano Lett. · 2007 · 7 · 170610.1021/nl070698f ↗
23. Liang K. · Adv. Mater. · 2011 · 23 · H27310.1002/adma.201101690 ↗
24. Du J. · J. Am. Chem. Soc. · 2005 · 127 · 1798210.1021/ja056514l ↗
25. Lomas H. · Small · 2011 · 7 · 210910.1002/smll.201100744 ↗
26. Meister A. · Annu. Rev. Biochem. · 1983 · 52 · 71110.1146/annurev.bi.52.070183.003431 ↗
27. Loretta L. · Nanoscale · 2010 · 2 · 45810.1039/b9nr00341j ↗
28. Kamphuis M. M. J. · J. Am. Chem. Soc. · 2010 · 132 · 1588110.1021/ja106405c ↗
29. Johnston A. P. R. · ACS Nano · 2012 · 6 · 666710.1021/nn3010476 ↗
30. Gao C. · Langmuir · 2001 · 17 · 349110.1021/la0015516 ↗
31. Li C. · Adv. Drug Delivery Rev. · 2002 · 54 · 69510.1016/S0169-409X(02)00045-5 ↗
32. Wang Y. · Adv. Mater. · 2010 · 22 · 429310.1002/adma.201001497 ↗
33. Bauhuber S. · Adv. Mater. · 2009 · 21 · 328610.1002/adma.200802453 ↗
34. Banerjee R. · J. Biol. Chem. · 2012 · 287 · 439710.1074/jbc.R111.287995 ↗
35. Griffith O. W. · Proc. Natl. Acad. Sci. U.S.A. · 1979 · 76 · 560610.1073/pnas.76.11.5606 ↗
36. Jiang X. · Infect. Immun. · 2008 · 76 · 239210.1128/IAI.01584-07 ↗
37. Steinman R. M. · Annu. Rev. Immunol. · 1991 · 9 · 27110.1146/annurev.iy.09.040191.001415 ↗
38. Yan Y. · ACS Nano · 2010 · 4 · 292810.1021/nn100173h ↗
39. Sexton A. · ACS Nano · 2009 · 3 · 339110.1021/nn900715g ↗